Frontline® Spot-On is a phenylpyrazole insecticide and is effective to control ticks, fleas, lice and mites on dogs
Directions for use:
Break the snap-off top from the spot-on pipette along the scored line. Part the coat between the shoulder blades until the skin is visible. Place the tip of the pipette on the skin and squeeze several times to empty its contents directly onto the skin only at one spot.
The product will spread naturally from the application site to cover the entire surface of the dog within 24 hours. Treated animals should not be handled or played with until application site is dry.
Frontline® Spot-On will also effectively treat ear mites infection if 2 drops are applied into each ear canal.
Frontline® Spot-On Dog is indicated for dogs over 10 weeks old and can be used on breeding, pregnant and nursing dogs.
PREVICOX™ (firocoxib) is a non-steroidal anti-inflammatory drug (NSAID) belonging to the Coxib group which has been selected and developed specifically for veterinary use. As a Coxib it acts by selective inhibition of cyclooxygenase-2 (COX-2)- mediated prostaglandin synthesis while sparing cyclooxygenase-1 (COX-1) – mediated prostaglandin synthesis.
PREVICOX™ has demonstrated at least 350-fold selectivity for COX-2 over COX-1 in in vitro canine whole blood assays. Importantly, no COX-1 inhibition occurs in vitro at levels observed in plasma after therapeutic doses.
• Relief of pain and control of inflammation associated with osteoarthritis and other musculoskeletal disorders.
• Effective control of post-operative pain associated with surgery; including soft tissue, orthopedic and dental procedures.
5mg/kg Once a day, with or without food.
recombinant virus-vectored technology uses only the genetic material that protect against:
• Canine Distemper Virus
• Canine Parvovirus
• Canine Adenovirus Type II
• Canine Parainfluenza Virus
• Canine Coronavirus
• Leptospira canicola
• Leptospira icterohaemorrhagiae
Primary vaccination for puppies:
1st vaccine: 8 weeks of age
2nd vaccine: 12 weeks of age
3rd vaccine: 16 weeks of age
One year later
Triennially for core vaccine
Annually for non-core vaccine